Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
A new covid variant, known as nimbus (scientifically NB.1.8.1), is causing concern among health experts as cases rise globally. The variant, a descendant of omicron, has been detected in several countries, including China, Singapore, Hong Kong, and the UK. While its symptoms are largely similar to previous covid strains, doctors have identified a distinctive new symptom: a razor blade sore throat, characterised by an intense stabbing pain when swallowing.
Experts warn that nimbus may be more efficient at infecting human cells than earlier variants, which could lead to increased transmission rates. Although there is no current evidence to suggest that it causes more severe illness than its predecessors, the rapid spread has raised concerns, particularly among vulnerable groups.
Symptoms of nimbus
Like previous Covid variants, nimbus presents with a range of symptoms, including fever, muscle aches, congestion, and shortness of breath. However, one symptom, in particular, is capturing attention—the razor blade sore throat. This sensation, described by medical experts as a sharp, stabbing pain at the back of the throat, makes swallowing extremely uncomfortable.
Other symptoms include redness in the throat, swollen neck glands, and general discomfort when eating or drinking. Some patients have also reported experiencing fatigue, headaches, and a persistent cough. While these symptoms may overlap with those of earlier variants, doctors emphasise that the severity and persistence of the sore throat are unique to nimbus.
Spread and concerns
Although only a small number of cases have officially been recorded in the UK, experts believe the actual spread of nimbus could be significantly wider. This is due to the decline in routine Covid testing since the height of the pandemic. According to UK Health Security Agency (UKHSA) data, the number of people testing positive for Covid has increased significantly in recent months. Reports indicate that infection rates have surged by 97% compared to figures recorded earlier in the year.
Virologists are warning that the number of Covid cases could continue to rise, particularly as summer approaches. Increased social interaction, crowded events, and holiday travel all create conditions for virus transmission. Professor Lawrence Young, a virologist at Warwick University, notes that while many respiratory viruses, such as flu, tend to subside in warmer climates, Covid continues to spread even in hot and humid weather. This makes it difficult to predict the scale of a possible summer wave.
Another concerning aspect is that population immunity, whether from vaccination or prior infection, appears to be waning over time. This means that even those who have had previous covid infections or vaccinations may still be at risk of catching nimbus.
Severity and vaccination
Laboratory studies suggest that nimbus is capable of infecting human cells more efficiently than previous strains. While there is no evidence indicating that it leads to more severe illness or higher fatality rates than earlier Covid variants, doctors stress that infection can still be dangerous for vulnerable individuals.
In May alone, Covid was a contributing factor in the deaths of over 300 people in England. The elderly, individuals with weakened immune systems, and those with pre-existing medical conditions remain particularly at risk.
The UKHSA is closely monitoring its progression and is assessing its impact on public healthiStock
Vaccination continues to be the strongest defence against severe illness. Experts say that current Covid vaccines, reformulated to target omicron-related variants, are expected to offer protection against nimbus. Research indicates that individuals who received a Covid booster jab as part of last spring’s vaccination campaign were 45% less likely to require hospital care following infection, compared to those who had not been vaccinated.
Global outlook
According to the World Health Organisation (WHO), nimbus now accounts for 10.7% of global Covid cases, a sharp increase from just 2.5% a month earlier. The UKHSA is closely monitoring its progression and is assessing its impact on public health.
Dr Gayatri Amirthalingam, deputy director of the UKHSA, has stated that the organisation is keeping track of all available data related to Covid variants in the UK and abroad. While nimbus has only been detected in small numbers in the UK so far, international data indicates that it is growing as a proportion of all Covid cases worldwide.
Preventative measures and vaccination eligibility
Health authorities continue to urge eligible individuals to receive their Covid vaccinations. In the UK, free vaccines are available for specific groups, including people aged 75 and older, care home residents, and those with weakened immune systems. This includes patients undergoing cancer treatment, organ transplant recipients, and individuals with genetic disorders that affect the immune system.
Getting vaccinated remains essential in protecting against severe illness and hospitalisation. While nimbus may not be more lethal than previous variants, experts emphasise that its ability to infect cells efficiently makes it highly transmissible. Vigilance, personal hygiene, and vaccination all play crucial roles in reducing the risk of infection.
The spread
The emergence of the nimbus variant is a stark reminder that Covid continues to evolve. While symptoms are similar to previous strains, the distinct razor blade sore throat is emerging as a defining characteristic of the latest variant. Experts warn that its ability to spread efficiently could lead to a summer surge in cases, particularly as population immunity declines.
Although there is no evidence that nimbus causes more severe illness than past variants, it remains a threat to vulnerable individuals. Health officials continue to recommend vaccination as the best means of protection. With the UKHSA closely monitoring its spread, staying informed and maintaining caution remain essential as the situation develops.
How noticing the changes in my father taught me the importance of early action, patience, and love
I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.
Earlier this year, I had the privilege of looking after my parents – they lived with me while their old house was being sold, and their new house was being renovated.
Within this time, I noticed things happening to my dad (Chamanlal Mulji), an 81-year-old retired joiner. Dad was known as Simba when he lived in Zanzibar, East Africa because he was like a lion. A man in fairly good health, despite being an ex-smoker, he’d only had heart surgery back in 2017. In the last few years, he was having some health issues, but certain things, like his walking and driving becoming slow, and his memory failing, we just put down to old age. Now, my dad was older than my friend’s dad. Many of whom in their 70’s, dad, at 81 was an older dad, not common back in the seventies when he married my mum.
It was only when I spent extended time around my parents that I started noticing that certain things weren’t just due to old age. Some physical symptoms were more serious, but certain things like forgetting that the front door wasn’t the bathroom door, and talking about old memories thinking that they had recently happened rang alarm bells for me and I suspected that he might have dementia.
Dementia generally happens in old age when the brain starts to shrink. Someone described it to me as a person’s brain being like a bookshelf. The books at the top of the shelf are the new memories and the books at the bottom are the new memories. The books at the top have fallen off, leaving only the old memories being remembered. People with dementia are also highly likely to suffer from strokes.
Sadly, my dad was one of the few that suffered a stroke and passed away on 28th June 2025. If you have a parent, family member or anyone you know and you suspect that they might have dementia, please talk to your GP straight away. Waiting lists within the NHS are extremely LONG so the quicker people with dementia are treated, the better. Sadly, the illness cannot be reversed but medication can help it from getting worse.
One thing I would also advise is to have patience. Those suffering with dementia can be agitated and often become aggressive, but that’s only because they’re frustrated that they cannot do things the way they used to.
The disease might hide the person underneath, but there’s still a person in there who needs your love and attention.” - Jamie Calandriello
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro
Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
A new discount deal with UK suppliers will limit the increase for patients.
Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
NHS pricing remains unaffected due to separate arrangements.
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.
Why the price rise was announced
Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.
Discount deal for UK suppliers
The revised agreement will see the top-dose price set at £247.50 for suppliers. While pharmacies and private providers will still add their own margins, the increase for patients is now likely to remain under 50% for higher doses, and even lower for smaller doses.
Eli Lilly confirmed:
“We are working with private providers on commercial arrangements to maintain affordability and expect these to be passed onto patients when the change is effective on 1 September.”
Impact on consumers
Around 1.5 million people in the UK are currently on weight-loss drugs, with more than half using Mounjaro. Most of these patients—around 90%—pay privately through online services or high street pharmacies.
Prices vary between providers, depending on the level of lifestyle and dietary support offered alongside the injections.
Olivier Picard of the National Pharmacy Association said:
“This rebate will mitigate some of the impact of the increase, but patients should still anticipate seeing a rise in prices from 1 September.”
NHS pricing unchanged
The deal does not affect the NHS, which has secured its own heavily-discounted price for patients prescribed the weekly injection.
Mounjaro works by helping patients feel fuller for longer, reducing food intake and supporting weight loss of up to 20% of body weight.
Keep ReadingShow less
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)
CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.
GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. Research estimates chickenpox in childhood leads to £24 million in lost income and productivity annually.
Minister of State for Care, Stephen Kinnock, said: “We’re giving parents the power to protect their children from chickenpox and its serious complications, while keeping them in nursery or the classroom where they belong and preventing parents from scrambling for childcare or having to miss work. This vaccine puts children’s health first and gives working families the support they deserve. As part of our Plan for Change, we want to give every child the best possible start in life, and this rollout will help to do exactly that.”
Dr Gayatri Amirthalingam, Deputy Director of Immunisation at the UK Health Security Agency, said: “Most parents probably consider chickenpox to be a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and tragically, while rare, it can be fatal. It is excellent news that from next January we will be introducing a vaccine to protect against chickenpox into the NHS routine childhood vaccination programme – helping prevent what is for most a nasty illness and for those who develop severe symptoms, it could be a life saver.”
Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said: “This is a hugely positive moment for families as the NHS gets ready to roll out a vaccine to protect children against chickenpox for the first time, adding to the arsenal of other routine jabs that safeguard against serious illness.”
The eligibility criteria will be set out in clinical guidance, and parents will be contacted by their GP surgery if their child is eligible.
WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.
Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.
“For so long, so many women haven’t been listened to by the world of medicine,” Munchetty said. “I knew this from my own experience of not being given adequate pain relief, or waiting years for a diagnosis. My motivation was to help women and people who love women to advocate better for women’s health.”
The book blends Munchetty’s personal journey with the voices of other women who have faced similar struggles, alongside expert insights from medical professionals. Its purpose, she said, is clear: to empower people to fight for their health.
“We need to be unafraid of saying how we have been weakened by our symptoms,” the BBC presenter said.
“Too often, we try to keep afloat, keep our head above water, but we don’t want to seem weak. That needs to change.”
Munchetty’s candour is striking. She describes the shame of being told her excruciating periods were “just normal,” leaving her to feel weak and whiny for struggling.
“You might as well have told me people have heart attacks while I’m having a heart attack,” she said. “Debilitating pain is serious — it may not be lifelimiting, but it is life-impacting.”
Her determination to challenge that culture led to her giving evidence in parliament, contributing to what became a Women and Equalities Committee report, published in December 2024.
The report made headlines for its stark conclusion: medical misogyny exists.
For Munchetty, seeing that phrase in black and white was transformative. “It was almost self-affirming,” she said. “We now know it’s there, so we can challenge it. Women can say: I know my body, I know there’s not enough research, and I am entitled to push for answers.”
The parliamentary report went further than acknowledgement. It called for ring-fenced funding for women’s health hubs, better training for GPs, and greater investment in research into reproductive conditions like adenomyosis and endometriosis.
It highlighted how symptoms are routinely dismissed as “normal,” delaying diagnosis and disrupting women’s careers, education and daily lives. Munchetty wrote in her book — referencing the report — that medical misogyny is not about blaming individual doctors, but about challenging a system built on insufficient research into women’s bodies.
“It gives women the language and the confidence to not just be heard, but to insist on being taken seriously,” she wrote.
Her book also tackles the additional barriers faced by women from minority communities, who may be discouraged by stigma or embarrassment from speaking about menstruation or menopause. To them, Munchetty has a clear message: “You are so much more valuable than you realise. If you don’t prioritise your health, you are lessening your ability to hold up everyone around you.”
Those featured in the book are friends, colleagues, charities and everyday women who contributed their stories, many for the first time. “I was surprised at how many friends are in that book with such powerful experiences,” Munchetty said.
“It told me all the more that we’re not speaking about it, and that it is sadly so very common.”
At a launch event for the book, contributors, family and experts filled the room with what Munchetty describes as an “electric and inspiring atmosphere.”
She said, “It was full of joy, of women who felt safe to speak up and be heard. This is not a whiny book — it’s a positive book. People felt they were part of making things better, part of this women’s health revolution.”
For Munchetty, writing the book was exhausting, but transformative, she said.
“I never thought I’d be an author. I’m a journalist. But this is journalism — facilitating people’s stories to be told powerfully and truthfully. People trusted me, and I’m proud of that.”
And Munchetty’s aim is for the book to be a tool for change: arming women with the language, confidence and strategies to advocate for their health.
“It’s not easy to admit you need help, and it’s not instinctive for women to prioritise themselves,” she said. “But this book will help you do that. It’s the silent friend who has your back and gives you strength.”
It’s Probably Nothing - Critical Conversations on the Women’s Health Crisis is now available in all good bookshops
Keep ReadingShow less
Williams explained that her weight challenges began after the birth of her first daughter
Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
The tennis legend says the treatment enhanced her existing healthy lifestyle
She stresses that weight loss should not change self-image or self-confidence
Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.
The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.
“I feel great,” Williams said. “I feel really good and healthy. I feel light physically and light mentally.”
Postpartum struggles
Williams explained that her weight challenges began after the birth of her first daughter, Alexis Olympia, in 2017. Despite training intensively and eating healthily, she found it difficult to return to her preferred weight.
“I never was able to get to the weight I needed to be, no matter what I did, no matter how much I trained,” she admitted. “It was frustrating to work so hard and not see results.”
She experienced the same plateau after giving birth to her second daughter, Adira River, in 2023. Although she initially shed weight quickly, progress soon stalled. “I never lost another pound,” she recalled.
Turning to treatment
Determined to try a new approach, Williams consulted doctors through Ro, a direct-to-patient healthcare company, and began a GLP-1 course once she had finished breastfeeding. The medication, also known as a glucagon-like peptide-1 receptor agonist, is commonly marketed under brand names such as Ozempic and Mounjaro.
“I did a lot of research before I started,” she explained. “I wanted to know if it was a shortcut or if it could really help me. In the end, it felt like the right decision.”
Williams, who is now a patient ambassador for Ro, said the injections made a noticeable difference. “I lost over 31 pounds and was really excited about that weight loss.”
Feeling better than ever
The Olympic gold medallist says she now feels stronger and more energetic.
“I can do more. I’m more active. My joints don’t hurt as much. Even simple things like moving around are easier. I feel like I have a lot more energy.”
She emphasised that GLP-1 was not a substitute for discipline but a way to support her existing healthy habits. “GLP-1 helped me enhance everything I was already doing — eating healthy and working out, whether as a professional athlete or just at the gym every day.”
Confidence and body positivity
Despite her transformation, Williams stressed that her self-confidence has never depended on her size.
“Weight loss should never really change your self-image,” she said. “Women are judged about their bodies at any size, and I’m no stranger to that. I’ve always loved myself at every stage. The difference was that my body didn’t feel good carrying that extra weight after having children.”
She added that she encourages her daughters to embrace body confidence too. “It’s important to teach them to be confident at any size, just as I try to be. Looking back, whether I was smaller or heavier, I always felt confident — and I looked great too.”
Looking ahead
Williams says she plans to continue with the weekly GLP-1 injections as needed, alongside training for a half marathon. The gym remains her “favourite place to be” — and she intends to keep sharing her workouts with fans online.